Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Aubry

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1985
Cardioprotective and antidysrhythmic effects of alpha 1-adrenoceptor blockade during myocardial ischaemia and reperfusion in the dogM L Aubry, M J Davey, B Petch
Nouvelle Revue Francaise D'Hematologie|January 1, 1993
Contribution of platelet protein S (PS) to PS levels measured in plasmaM Alhenc-Gelas, M L Aubry, M Aiach
British Journal of Pharmacology|February 1, 1970
Aspects of the pharmacology of a new anthelmintic: pyrantelM L Aubry, P Cowell, M J Davey, et al.
Thrombosis and Haemostasis|February 11, 2000
Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein SM Alhenc-Gelas, S Gandrille, M L Aubry, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
Genetic variation at the estrogen receptor alpha locus in relation to venous thromboembolism risk among postmenopausal womenC Straczek, M Alhenc-Gelas, M L Aubry, et al.
Thrombosis and Haemostasis|January 12, 2001
The FXIII Val 34 Leu mutation and the risk of venous thrombosisM Alhenc-Gelas, J L Reny, M L Aubry, et al.
Lancet (London, England)|August 20, 1994
Unexplained thrombosis and factor V Leiden mutationM Alhenc-Gelos, S Gandrille, M L Aubry, et al.
Thrombosis and Haemostasis|May 11, 1999
Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genesM Alhenc-Gelas, E Arnaud, V Nicaud, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1995
Protein C infusion in a patient with inherited protein C deficiency caused by two missense mutations: Arg 178 to Gln and Arg-1 to HisM Alhenc-Gelas, J Emmerich, S Gandrille, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Thrombomodulin promoter mutations, venous thrombosis, and varicose veinsL Le Flem, L Mennen, M L Aubry, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Pharmacology|January 1, 1985
Cardioprotective and antidysrhythmic effects of alpha 1-adrenoceptor blockade during myocardial ischaemia and reperfusion in the dogM L Aubry, M J Davey, B Petch
Nouvelle Revue Francaise D'Hematologie|January 1, 1993
Contribution of platelet protein S (PS) to PS levels measured in plasmaM Alhenc-Gelas, M L Aubry, M Aiach
British Journal of Pharmacology|February 1, 1970
Aspects of the pharmacology of a new anthelmintic: pyrantelM L Aubry, P Cowell, M J Davey, et al.
Thrombosis and Haemostasis|February 11, 2000
Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein SM Alhenc-Gelas, S Gandrille, M L Aubry, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
Genetic variation at the estrogen receptor alpha locus in relation to venous thromboembolism risk among postmenopausal womenC Straczek, M Alhenc-Gelas, M L Aubry, et al.
Thrombosis and Haemostasis|January 12, 2001
The FXIII Val 34 Leu mutation and the risk of venous thrombosisM Alhenc-Gelas, J L Reny, M L Aubry, et al.
Lancet (London, England)|August 20, 1994
Unexplained thrombosis and factor V Leiden mutationM Alhenc-Gelos, S Gandrille, M L Aubry, et al.
Thrombosis and Haemostasis|May 11, 1999
Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genesM Alhenc-Gelas, E Arnaud, V Nicaud, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1995
Protein C infusion in a patient with inherited protein C deficiency caused by two missense mutations: Arg 178 to Gln and Arg-1 to HisM Alhenc-Gelas, J Emmerich, S Gandrille, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Thrombomodulin promoter mutations, venous thrombosis, and varicose veinsL Le Flem, L Mennen, M L Aubry, et al.
Pageof 2